640 related articles for article (PubMed ID: 16436275)
1. Corticosteroids: the drugs to beat.
Barnes PJ
Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroid effects on cell signalling.
Barnes PJ
Eur Respir J; 2006 Feb; 27(2):413-26. PubMed ID: 16452600
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase-2 and airway disease.
Barnes PJ
Ther Adv Respir Dis; 2009 Oct; 3(5):235-43. PubMed ID: 19812111
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.
Mroz RM; Noparlik J; Chyczewska E; Braszko JJ; Holownia A
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):453-60. PubMed ID: 18204158
[TBL] [Abstract][Full Text] [Related]
5. Histone acetylation and deacetylation: importance in inflammatory lung diseases.
Barnes PJ; Adcock IM; Ito K
Eur Respir J; 2005 Mar; 25(3):552-63. PubMed ID: 15738302
[TBL] [Abstract][Full Text] [Related]
6. Impact of protein acetylation in inflammatory lung diseases.
Ito K; Charron CE; Adcock IM
Pharmacol Ther; 2007 Nov; 116(2):249-65. PubMed ID: 17720252
[TBL] [Abstract][Full Text] [Related]
7. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease.
Barnes PJ
Proc Am Thorac Soc; 2009 Dec; 6(8):693-6. PubMed ID: 20008877
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.
Barnes PJ
J Allergy Clin Immunol; 2013 Mar; 131(3):636-45. PubMed ID: 23360759
[TBL] [Abstract][Full Text] [Related]
9. How corticosteroids control inflammation: Quintiles Prize Lecture 2005.
Barnes PJ
Br J Pharmacol; 2006 Jun; 148(3):245-54. PubMed ID: 16604091
[TBL] [Abstract][Full Text] [Related]
10. Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin.
Biswas S; Rahman I
Mol Nutr Food Res; 2008 Sep; 52(9):987-94. PubMed ID: 18327875
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.
Barnes PJ; Ito K; Adcock IM
Lancet; 2004 Feb; 363(9410):731-3. PubMed ID: 15001333
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms and resistance in glucocorticoid control of inflammation.
Barnes PJ
J Steroid Biochem Mol Biol; 2010 May; 120(2-3):76-85. PubMed ID: 20188830
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms and cellular effects of glucocorticosteroids.
Barnes PJ
Immunol Allergy Clin North Am; 2005 Aug; 25(3):451-68. PubMed ID: 16054537
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticosteroids.
Barnes PJ
Handb Exp Pharmacol; 2017; 237():93-115. PubMed ID: 27796513
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of airway inflammation.
Adcock IM; Tsaprouni L; Bhavsar P; Ito K
Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
[TBL] [Abstract][Full Text] [Related]
16. The role of histone deacetylases in asthma and allergic diseases.
Bhavsar P; Ahmad T; Adcock IM
J Allergy Clin Immunol; 2008 Mar; 121(3):580-4. PubMed ID: 18234319
[TBL] [Abstract][Full Text] [Related]
17. [Molecular bases of anti-asthma action of corticosteroids].
Pelaia G; Marsico SA
Recenti Prog Med; 1995 Jun; 86(6):248-56. PubMed ID: 7624587
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid resistance in inflammatory diseases.
Barnes PJ; Adcock IM
Lancet; 2009 May; 373(9678):1905-17. PubMed ID: 19482216
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid resistance in airway disease.
Barnes PJ
Proc Am Thorac Soc; 2004; 1(3):264-8. PubMed ID: 16113444
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid pathways in chronic obstructive pulmonary disease therapy.
Adcock IM; Ito K
Proc Am Thorac Soc; 2005; 2(4):313-9; discussion 340-1. PubMed ID: 16267355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
